Roche shares pop 5% on $5.3 billion obesity drug deal with Zealand Pharma
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand Pharma's obesity drug candidate.
Roche
since
auto-detected in 213 stories
58 days ago
Roche shares pop 5% on $5.3 billion obesity drug deal with Zealand Pharma
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand Pharma's obesity drug candidate.
Roche signs biggest-ever obesity drug deal
Swiss pharma group agrees $5.3bn licensing agreement for next-generation treatment made by Zealand Pharma
|← first ← previous page 2 of 2